New Perspectives and Future Directions in Management of Chronic Respiratory Diseases
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 1320
Special Issue Editors
Interests: chronic respiratory diseases/COPD; asthma; sleep medicine; interstitial lung diseases; pulmonary infections; sarcoidosis; tabacology; life style medicine
Special Issues, Collections and Topics in MDPI journals
Interests: COPD; severe asthma; bronchiectasis; chronic cough
Special Issue Information
Dear Colleagues,
Chronic respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), obstructive sleep apnea (OSA), interstitial lung diseases, pneumonitis, sarcoidosis, and other lung conditions, represent a major challenge of health systems around the world. In 2017, it was estimated that 545 million people suffer from a chronic respiratory disease, demonstrating an increase of almost 40% since 1990, and these chronic respiratory diseases were the third leading cause of death.
This type of disorders affects the lungs and other parts of the respiratory system, and slowly spreads over several years. Smoking tobacco, second-hand smoking, chemical fumes, dust, and other variants of air pollution are involved in the development and progression of these disease. Beside them, behavioral risk factors and metabolic risk factors contribute to the progression and increase the risk of exacerbations.
According to WHO, around the world, there is a desire to reduce the morbidity, disability, and premature mortality related to respiratory disease because it is well known that these diseases have frequent exacerbations and impact the quality of life of patients and medical systems, resulting in high hospitalization costs.
To our knowledge, the underlying mechanisms are not completely discovered and described, as the diagnosis of chronic respiratory diseases in an advanced stage and the existing definition could be misleading. To handle with the reversion and disease progression achieving lung parenchyma regeneration, there is a rapid need for finding an efficient treatment. Understanding the pathophysiology and the molecular mechanisms could help in the identification of potential and novel targets for reversing disease degeneration.
This Special Issue aims to identify new strategies focused on the diagnosis and personalized treatment of chronic respiratory diseases regarding each disease and stage of it, with varying impacts on prognosis and mortality.
Prof. Dr. Doina Adina Todea
Dr. Ji-Ho Lee
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chronic respiratory diseases
- biomarkers
- pathophysiology and molecular mechanisms
- risk factors
- comorbidities
- personalized treatment
- quality of life
- prognosis and mortality
